Related Experiment Video
Updated: Apr 14, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Multiple sclerosis in two patients with coexisting Wilson's disease.
Karolina Dzieżyc1, Tomasz Litwin1, Anna Członkowska2
12nd Department of Neurology, Institute of Psychiatry and Neurology, Sobieskiego 9, 02 957 Warsaw, Poland.
Two patients with coexisting Wilson disease (WD) and multiple sclerosis (MS) showed mild MS progression. Researchers suggest free copper in WD may have an immunosuppressive effect, potentially mitigating MS severity.
Area of Science:
- Neurology
- Genetics
- Immunology
Background:
- Wilson disease (WD) is an inherited copper metabolism disorder affecting the liver and nervous system.
- Multiple sclerosis (MS) is an autoimmune inflammatory disease impacting the central nervous system.
- Co-occurrence of WD and MS is rare, presenting unique clinical challenges.
Purpose of the Study:
- To report on two patients diagnosed with both Wilson disease and multiple sclerosis.
- To investigate the potential interaction between WD and MS, particularly regarding disease course and severity.
Main Methods:
- Case study of two patients with confirmed diagnoses of both WD and MS.
- Clinical observation and neurological assessment over extended periods (17 and 12 years).
- Evaluation of symptoms related to both WD (hepatic, neurological) and MS (neurological).
Main Results:
- Both patients were diagnosed with MS prior to WD.
- Neurological symptoms consistent with MS were present in both patients.
- The first patient exhibited classic WD neurological and physical signs; the second had liver injury but no WD neurological signs.
- Both patients experienced a very mild clinical course of MS during long-term observation.
Conclusions:
- The co-occurrence of WD and MS is documented in these cases.
- The mild MS progression in these patients may be linked to the immunosuppressive effects of excess free copper associated with Wilson disease.
More Related Videos
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment